Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Hernandez
Yuting Zhang

Showing results (11-20 of 1,451) with videos related to

Pageof 146
Sort By:
Journal of Managed Care & Specialty Pharmacy|March 23, 2016
Evaluating the Initiation of Novel Oral Anticoagulants in Medicare BeneficiariesSeo Hyon Baik, Inmaculada Hernandez, Yuting Zhang
Journal of Managed Care & Specialty Pharmacy|January 27, 2017
Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected CountriesYuting Zhang, Hana Chantel Hueser, Inmaculada Hernandez
Thrombosis Research|October 25, 2016
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney functionInmaculada Hernandez, Kenneth J Smith, Yuting Zhang
Journal of the American Heart Association|January 6, 2018
Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society GuidelineMatthew P Gray, Samir Saba, Yuting Zhang, et al.
American Journal of Alzheimer'S Disease and Other Dementias|May 9, 2020
Risk Factors for Cardiovascular Events in Patients on Antidementia MedicationsMeiqi He, James M Stevenson, Yuting Zhang, et al.
JAMA Network Open|January 16, 2019
Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D BeneficiariesInmaculada Hernandez, Meiqi He, Maria M Brooks, et al.
JAMA Internal Medicine|November 4, 2014
Risk of bleeding with dabigatran in atrial fibrillationInmaculada Hernandez, Seo Hyon Baik, Antonio Piñera, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 10, 2018
Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of BleedingAlexa R Hospodar, Kenneth J Smith, Yuting Zhang, et al.
JAMA Network Open|March 2, 2019
Association of Antidementia Therapies With Time to Skilled Nursing Facility Admission and Cardiovascular Events Among Elderly Adults With Alzheimer DiseaseAlvaro San-Juan-Rodriguez, Yuting Zhang, Meiqi He, et al.
Stroke|December 3, 2016
Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial FibrillationInmaculada Hernandez, Yuting Zhang, Maria M Brooks, et al.
Pageof 146

Showing results (11-20 of 1,451) with videos related to

Sort By:
Pageof 146
Journal of Managed Care & Specialty Pharmacy|March 23, 2016
Evaluating the Initiation of Novel Oral Anticoagulants in Medicare BeneficiariesSeo Hyon Baik, Inmaculada Hernandez, Yuting Zhang
Journal of Managed Care & Specialty Pharmacy|January 27, 2017
Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected CountriesYuting Zhang, Hana Chantel Hueser, Inmaculada Hernandez
Thrombosis Research|October 25, 2016
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney functionInmaculada Hernandez, Kenneth J Smith, Yuting Zhang
Journal of the American Heart Association|January 6, 2018
Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society GuidelineMatthew P Gray, Samir Saba, Yuting Zhang, et al.
American Journal of Alzheimer'S Disease and Other Dementias|May 9, 2020
Risk Factors for Cardiovascular Events in Patients on Antidementia MedicationsMeiqi He, James M Stevenson, Yuting Zhang, et al.
JAMA Network Open|January 16, 2019
Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D BeneficiariesInmaculada Hernandez, Meiqi He, Maria M Brooks, et al.
JAMA Internal Medicine|November 4, 2014
Risk of bleeding with dabigatran in atrial fibrillationInmaculada Hernandez, Seo Hyon Baik, Antonio Piñera, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 10, 2018
Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of BleedingAlexa R Hospodar, Kenneth J Smith, Yuting Zhang, et al.
JAMA Network Open|March 2, 2019
Association of Antidementia Therapies With Time to Skilled Nursing Facility Admission and Cardiovascular Events Among Elderly Adults With Alzheimer DiseaseAlvaro San-Juan-Rodriguez, Yuting Zhang, Meiqi He, et al.
Stroke|December 3, 2016
Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial FibrillationInmaculada Hernandez, Yuting Zhang, Maria M Brooks, et al.
Pageof 146